Search - tctmd.com

Displaying 1 - 20 of 296

Sort: Relevancy | Date

Presentation TCT 2025

Regulatory Approvals for Therapies for Patients with “Not Suitable for Conventional Therapy?"

Presenter: Jeffrey Popma

October 28, 2025

News Daily News

Oral Semaglutide Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients

Caitlin E. Cox

October 22, 2025

News Daily News

New ACC Consensus Document Helps Clinicians Navigate Issues Around TR

Todd Neale

September 26, 2025

FDA Expands Evolut Indication to Include Redo TAVI

News Daily News

FDA Expands Evolut Indications to Include Redo TAVI

Yael L. Maxwell

August 29, 2025

News Daily News

Evolocumab Gains Expanded Indication for Primary Prevention

Michael O'Riordan

August 26, 2025

News Daily News

Inclisiran Gains Indication as Stand-alone Therapy to Reduce LDL Cholesterol

Michael O'Riordan

August 06, 2025

News Daily News

FDA Approves Finerenone for HF Patients With Mildly Reduced or Preserved EF

Caitlin E. Cox

July 14, 2025

News Daily News

FDA Approves Triple Therapy Polypill for High Blood Pressure

Michael O'Riordan

June 10, 2025

News Daily News

FDA Approves TAVI for Asymptomatic Patients With Severe Aortic Stenosis

Michael O'Riordan

May 01, 2025

News Daily News

One-Year Mortality With TAVI Rose in Recent Years: TVT Registry

Caitlin E. Cox

March 25, 2025

News Daily News

Less Plaque Progression With CAC-Guided Primary Prevention: CAUGHT-CAD

Michael O'Riordan

March 06, 2025

News Daily News

Coverage and Use of Impella and Watchman: A Tale of Four Countries

Michael O'Riordan

March 04, 2025

News Daily News

‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials

Michael O'Riordan

February 20, 2025

News Daily News

Acoramidis Approved in Europe for ATTR Cardiomyopathy

Michael O'Riordan

February 12, 2025

News Opinion Off Script

Q&A: Wayne Batchelor Reflects on the State of Medical Research Early in the Second Trump Term

Wayne Batchelor, MD, MHS, MBA

February 07, 2025

News Opinion Editor's Corner

TCTMD’s Biggest News of 2024: Stories, Videos, and More

Shelley Wood

January 01, 2025

News Daily News

Top Structural Heart News of 2024

L.A. McKeown

December 29, 2024

News Daily News

Top Heart Rhythm News of 2024

Todd Neale

December 27, 2024

News Daily News

Tirzepatide Gets FDA Approval for Sleep Apnea in Adults With Obesity

L.A. McKeown

December 23, 2024

News Daily News

Editor’s Pick: TCTMD’s Best Long Reads of 2024

Shelley Wood

December 17, 2024

Advertisement

Regulatory Approvals for Therapies for Patients with “Not Suitable for Conventional Therapy?"

Oral Semaglutide Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients

New ACC Consensus Document Helps Clinicians Navigate Issues Around TR

FDA Expands Evolut Indications to Include Redo TAVI

Evolocumab Gains Expanded Indication for Primary Prevention

Inclisiran Gains Indication as Stand-alone Therapy to Reduce LDL Cholesterol

FDA Approves Finerenone for HF Patients With Mildly Reduced or Preserved EF

FDA Approves Triple Therapy Polypill for High Blood Pressure

FDA Approves TAVI for Asymptomatic Patients With Severe Aortic Stenosis

One-Year Mortality With TAVI Rose in Recent Years: TVT Registry

Less Plaque Progression With CAC-Guided Primary Prevention: CAUGHT-CAD

Coverage and Use of Impella and Watchman: A Tale of Four Countries

‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials

Acoramidis Approved in Europe for ATTR Cardiomyopathy

Q&A: Wayne Batchelor Reflects on the State of Medical Research Early in the Second Trump Term

TCTMD’s Biggest News of 2024: Stories, Videos, and More

Top Structural Heart News of 2024

Top Heart Rhythm News of 2024

Tirzepatide Gets FDA Approval for Sleep Apnea in Adults With Obesity

Editor’s Pick: TCTMD’s Best Long Reads of 2024

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content